Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells

American Journal of Reproductive Immunology

Volumn 65, Issue 4, 2011, Pages 438-447

  Leizer, Aliza L ^a   Alvero, Ayesha B ^a   Fu, Han Hsuan ^a   Holmberg, Jennie C ^a   Cheng, Yung Chi ^a   Silasi, Dan Arin ^a   Rutherford, Thomas ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cells; Inflammation; Nuclear factor kappa B; Ovarian cancer; Ovarian cancer stem cells; TNF

Indexed keywords

CASPASE; CYTOKINE; ERIOCALYXIN B; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ORIDONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY CANCER; PRIORITY JOURNAL;

APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DITERPENES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; NEOPLASTIC STEM CELLS; NF-KAPPA B; OVARIAN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79952301399     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00914.x     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Clarke-Pearson DL: Clinical practice. Screening for ovarian cancer. N Engl J Med 2009; 361:170-177.
3. Schwartz PE: Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 2002; 107:99-118.
4. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002; 420:860-867.
5. Chen R, Alvero AB, Silasi DA, Mor G: Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 2007; 57:93-107.
6. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G: Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells. Oncogene 2008; 27:225-233.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-111.
8. Alvero AB, O'Malley D, Brown D, Kelly G, Garg M, Chen W, Rutherford T, Mor G: Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 2006; 106:599-608.
9. Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA, Mor G: Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 2009; 27:2405-2413.
10. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G: Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008; 27:4712-4723.
11. Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C, Rutherford T, Mor G: TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010; 29:3545-3553.
12. Wang L, Zhao WL, Yan JS, Liu P, Sun HP, Zhou GB, Weng ZY, Wu WL, Weng XQ, Sun XJ, Chen Z, Sun HD, Chen SJ: Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner. Cell Death Differ 2007; 14:306-317.
13. Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H, Koeffler HP: Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol 2003; 23:1187-1193.
14. Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, Brown D, Mor G: Phenoxodiol-an isoflavone analogue-induces apoptosis in chemo-resistant ovarian cancer cells. Oncogene 2003; 22:2611-2620.
15. Flick MB, O'Malley D, Rutherford T, Rodov S, Kamsteeg M, Hao XY, Schwartz PE, Kacinski BM, Mor G: Apoptosis-Based Evaluation Of Chemosensitivity In Ovarian Cancer Patients. J Soc Gynecol Investig 2004; 11:252-259.
16. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G: Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009; 8:158-166.
17. Alvero AB, Montagna MK, Chen R, Kim KH, Kyungjin K, Visintin I, Fu HH, Brown D, Mor G: NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. Cancer 2009; 115:3204-3216.
18. Cardenas I, Means RE, Aldo P, Koga K, Lang SM, Booth C, Manzur A, Oyarzun E, Romero R, Mor G: Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 2010; 185:1248-1257.
19. Luo JL, Kamata H, Karin M: The anti-death machinery in IKK/NF-kappaB signaling. J Clin Immunol 2005; 25:541-550.
20. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G: X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004; 10:33-41.
21. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6:203-208.
22. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr: Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999; 5:412-417.
23. Jin HS, Lee DH, Kim DH, Chung JH, Lee SJ, Lee TH: cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res 2009; 69:1782-1791.
24. Green JM, Alvero AB, Kohen F, Mor G: 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biol Ther 2009; 8:1747-1753.
25. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431:461-466.
26. Tang ED, Wang CY, Xiong Y, Guan KL: A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003; 278:37297-37305.
27. Yang F, Tang E, Guan K, Wang CY: IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 2003; 170:5630-5635.
28. Sapi E, Chen W, O'Malley D, Hao X, Dwipoyono B, Garg M, Kamsteeg M, Rutherford T, Mor G: Resistance of ovarian cancer cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Anticancer Drugs 2004; 14:567-578.
29. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-768.
30. Clarke MF, Fuller M: Stem cells and cancer: two faces of eve. Cell 2006; 124:1111-1115.
31. Jordan CT, Guzman ML, Noble M: Cancer stem cells. N Engl J Med 2006; 355:1253-1261.
32. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G: TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006; 66:3859-3868.
33. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F: Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15:730-738.
34. Lin EY, Pollard JW: Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004; 256:158-168; discussion 168-172, 259-169.
35. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71-78.
36. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, Lang RA, Pollard JW: A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE 2009; 4:e6562.
37. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-1659.
38. Cheng JQ, Jiang X, Fraser M, Li M, Dan HC, Sun M, Tsang BK: Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist Updat 2002; 5:131-146.
39. Holcik M, Gibson H, Korneluk RG: XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001; 6:253-261.
40. Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC: Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 2003; 9:2826-2836.
41. Alvero AB, Chen W, Sartorelli AC, Schwartz P, Rutherford T, Mor G: Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) induces apoptosis in ovarian cancer cells. J Soc Gynecol Investig 2006; 13:145-152.
42. Ditsworth D, Zong WX: NF-kappaB: key mediator of inflammation-associated cancer. Cancer Biol Ther 2004; 3:1214-1216.
43. Birbach A, Bailey ST, Ghosh S, Schmid JA: Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIK. J Cell Sci 2004; 117:3615-3624.